A method detection limit for potential in vivo arsenic measurements with a 50 W x-ray tube

Physics in Medicine and Biology

Volumn 51, Issue 21, 2006, Pages

  Studinski, Ryan C N ^a   McNeill, Fiona E ^b   O'Meara, Joanne M ^c   Chettle, David R ^b  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; COMPUTER SIMULATION; DRUG DOSAGE; MEASUREMENT THEORY; NUMERICAL METHODS; PRODUCT DESIGN; TISSUE; X RAY APPARATUS;

IN VIVO ARSENIC MEASUREMENTS; TISSUE-SIMULATING PHANTOMS; X-RAY FLUORESCENCE SYSTEMS;

BIOMEDICAL ENGINEERING;

ARSENIC;

ARTICLE; FLUORESCENCE; IN VIVO STUDY; PRIORITY JOURNAL; X RAY ANALYSIS;

ARSENIC; CALIBRATION; ELECTRONICS; EQUIPMENT DESIGN; HUMANS; MODELS, STATISTICAL; MONTE CARLO METHOD; PHANTOMS, IMAGING; SCATTERING, RADIATION; SPECTROMETRY, X-RAY EMISSION; X-RAYS;

EID: 33751178600     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/51/21/N01     Document Type: Article

References (20)

1. Ahlgren L, Lidén K, Mattsson S and Tejning S 1976 X-ray fluorescence analysis of lead in human skeleton in vivo Scand. J. Work Environ. Health 2 82-6
2. Ahlgren L and Mattsson S 1981 Cadmium in man measured in vivo by x-ray fluorescence analysis Phys. Med. Biol. 26 19-26
3. Bagshaw A P and Farquharson M J 2002 Simultaneous determination of iron, copper and zinc concentrations in skin phantoms using XRF spectrometry X-Ray Spectrom. 31 47-52
4. Bearden J A and Burr A F 1967 Reevaluation of X-ray atomic energy levels Rev. Mod. Phys. 39 125-42
5. Bevington P R 1969 Data Reduction and Error Analysis for the Physical Sciences (New York: McGraw-Hill)
6. Börjesson J, Barregärd L, Sällsten G, Schütz A, Jonson R, Alpsten M and Mattsson S 1995 In vivo XRF analysis of mercury: the relation between concentrations in the kidney and the urine Phys. Med. Biol. 40 413-26
7. Chen C-J, Chiou H-Y, Chiang M-H, Lin L-J and Tai T-Y 1996 Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure Arterioscler. Thromb. Vasc. Biol. 16 504-10
8. Das D, Chatterjee A, Mandal B K, Samanta G and Chakraborti D 1995 Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world: II. Arsenic concentration in drinking water, hair, mails, urine, skin-scale and liver tissue (biopsy) of the affected people Analyst 120 917-24
9. Firestone R B 1996 Table of Isotopes 8th edn (New York: Wiley)
10. Gorodetsky R, Goldfarb A, Dagan I and Rachmilewitz E A 1985 Noninvasive analysis of skin iron and zinc levels in b-thalassemia major and intermedia J. Lab. Clin. Med. 105 44-51
11. Guha Mazumder D N 2001 Arsenic and liver disease J. Indian Med. Assoc 99 311-20
12. Hoffer P B, Jones W B, Crawford R B, Beck R and Gottschalk A 1968 Fluorescent thyroid scanning: a new method of imaging the thyroid Radiology 90 342-4
13. Karim M M 2000 Arsenic in groundwater and health problems in Bangladesh Water Res. 34 304-10
14. Kyle R A and Pease G L 1965 Hematologic aspects of arsenic intoxication N. Engl. J. Med. 273 18-23
15. O'Meara J M, Chettle D R, McNeill F E and Webber C E 1997 The feasibility of measuring bone uranium concentrations in vivo using source excited K x-ray fluorescence Phys. Med. Biol. 42 1109-20
16. Pejović-Milić A, Stronach I M, Gyorffy J, Webber C E and Chettle D R 2004 Quantification of bone strontium levels in humans by in vivo x-ray fluorescence Med. Phys. 31 528-38
17. Schoolmeester W L and White D R 1980 Arsenic poisoning South. Med. J. 73 391-6
18. Schwartz R A 1997 Arsenic and the skin Int. J. Dermatol. 36 241-50
19. Smith A H, Hopenhyn-Rich C, Bates M N, Goeden H M, Hertz-Picciotto I, Duggan H M, Wood R, Kosnett M J and Smith M T 1992 Cancer risks from arsenic in drinking water Environ. Health Perspect. 97 259-67
20. Studinski R C N, McNeill F E, Chettle D R and O'Meara J M 2005 Estimation of a method detection limit for an in vivo XRF arsenic detection system Phys. Med. Biol. 50 521-30